News & Analysis on Clinical Trial Services & Contract Research And Development
Pliva, Eastern Europe's biggest drug maker by sales, saw its profits take a massive dive in the first quarter of 2006, as a huge loss of royalties could not be offset by the relatively small growth in its generics business.
Registration is now open for this year's International Society for Pharmaceutical Engineering (ISPE) European Congress. The topic of focus is science-based manufacturing for the next decade.
UK firm Avecia Biotechnology has been given a £1m (€1.5m) grant to lead a three year project to establish a faster and cheaper bioprocessing technology for advanced tissue engineering, primarily to develop new skin to heal burns victims.
DrugResearcher animal rights series
UK Prime Minister Tony Blair has made the unprecedented step of pledging his personal support for animal testing, provoking an angry reaction from anti-vivisectionists.
deCODE and Illumina have entered an agreement to develop and commercialise DNA-based diagnostics, in which deCODE will use Illumina's SNP genotyping platform to expand its contract genotyping business.
Berthold Technologies used Analytica to showcase its innovative new instruments that will open up new opportunities for users in bioimedical and pharmaceutical research.
Genentech has entered into a collaboration with biopharmaceutical firm Immunogen to develop a commercial manufacturing process for its anticancer drug trastuzumab (Herceptin) using its tumour-activated prodrug (TAP) technology.
Analytical instrument maker Thermo has announced it will promote compatibility between its RESULT software and CAMO's Unscrambler software, bringing together the most powerful near infrared (NIR) analysers in the industry.